Monitor for any strategic shifts in Innovative Medicine under Cavanaugh's leadership, but no near-term trading catalyst from this filing.
Price Chart
Executive Summary
Johnson & Johnson announced the retirement of Jennifer Taubert, EVP and Worldwide Chairman of Innovative Medicine, effective September 1, 2026, with Tom Cavanaugh appointed as her successor. This is a routine leadership transition at a mega-cap pharmaceutical company with a named internal replacement, carrying no material financial impact.
Key Facts
- Jennifer Taubert to retire as EVP, Worldwide Chairman, Innovative Medicine effective September 1, 2026.
- Tom Cavanaugh appointed as successor, effective September 1, 2026, and will join the Executive Committee.
- Taubert had a 21-year tenure at J&J; under her leadership, Innovative Medicine grew to more than $60 billion in annual revenue.
- Cavanaugh has nearly 30 years of biopharma experience, including 9 years at J&J and prior roles at Celgene.
Financial Impact
No financial impact disclosed; routine executive succession at a $617.8B market cap company.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000200406-26-000167 |
| Document: pressrelease08042026.htm | 0000200406-26-000167 |
| Document: 0000200406-26-000167-index-headers.html | 0000200406-26-000167 |
| Document: 0000200406-26-000167-index.html | 0000200406-26-000167 |
| Document: 0000200406-26-000167.txt | 0000200406-26-000167 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Court Ruling | $267.08 $267.28 | ▲ +0.07% | ▲ +0.73% | $258.66 (−3.15%) |
Aug 18, 2026 6w ago | Insider Cluster | $273.41 $270.00 | ▼ −1.25% | ▼ −0.86% | $258.66 (−5.39%) |
Aug 14, 2026 7w ago | Insider Cluster | $260.35 $270.24 | ▲ +3.80% | ▲ +5.17% | $258.66 (−0.65%) |
Aug 7, 2026 7w ago | Insider Cluster | $261.81 $262.37 | ▲ +0.21% | ▲ +0.26% | $258.66 (−1.20%) |
Aug 7, 2026 8w ago | Court Ruling | $259.24 $260.35 | ▼ −0.43% | ▼ −0.03% | $258.66 (+0.22%) |
Aug 4, 2026 8w ago | 8-K | $254.93 $259.80 | ▲ +1.91% | ▲ +2.01% | $258.66 (+1.46%) |
Jul 22, 2026 10w ago | Court Ruling | $255.63 $265.53 | ▼ −3.87% | ▼ −6.27% | $258.66 (−1.19%) |
Jul 15, 2026 11w ago | 8-K | $247.02 $255.63 | ▲ +3.49% | ▲ +4.47% | $258.66 (+4.71%) |
May 20, 2026 19w ago | Court Ruling | $229.12 $231.29 | ▲ +0.95% | ▼ −0.29% | $258.66 (+12.89%) |
May 13, 2026 20w ago | ANALYST-UPGRADE | $230.79 $231.58 | ▲ +0.34% | ▲ +1.06% | $258.66 (+12.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access